Insulin Enhances the Viability of Doxorubicin-Treated Luminal A Breast Cancer T-47D Cells
Fadhilla Resendryana Esthya, Novrita Padauleng, L. Prihatina et al.
· 0 citations
We have 3 of 9 papers
We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.
Not the right person? Other researchers publish under this name.
Insulin Enhances NF-κB Activation in Luminal A T -47D Breast Cancer Cells Exposed to Low-Dose Doxorubicin
Findings indicate that insulin increases NF-κB activation in doxorubicin -treated T-47D breast cancer cells and may sustain NF-κB activity against the cytotoxic effects of doxorubicin.
Wibisono Hasanul Muhtaram, Novrita Padauleng, Rizka Vidya Lestari et al.
· 0 citations
Open access
Jul 2026
Insulin-Induced NF-κB Activation May Contribute to Doxorubicin Resistance in Luminal A T-47D Breast Cancer Cells
Findings indicate that insulin increases NF-κB activation in doxorubicin-treated T-47D breast cancer cells and may sustain NF-κB activity against the cytotoxic effects of doxorubicin.
Wibisono Hasanul Muhtaram, Novrita Padauleng, Rizka Vidya Lestari
· Lombok Medical Journal · 0 citations